Amarantus BioScience Holdings, Inc. , a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced a development timeline for its LymPro Blood Test for Alzheimer's disease .
http://www.businesswire.com/news/topix/20130408005612/en
http://www.businesswire.com/news/topix/20130408005612/en
